Article

Design and Preclinical Development of a Novel In Vivo Chimeric Antigen Receptor (CAR) Product for B-Cell Involved Diseases

2025-04-30

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: eb86b405-c971-54d1-aebc-8504b0376971
DOI: 10.1016/j.jcyt.2025.03.323

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Design and Preclinical Development of a Novel In Vivo Chimeric Antigen Receptor (CAR) Product for B-Cell Involved DiseasesDOI 10.1016/j.jcyt.2025.03.323Read

Chimeric Antigen Receptors: A Paradigm Shift in ImmunotherapySemantic proximity Read

The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T CellsSemantic proximity Read

Building Better Chimeric Antigen Receptors for Adoptive T Cell TherapySemantic proximity Read

T Cell Activation Machinery: Form and Function in Natural and Engineered Immune ReceptorsSemantic proximity Read

Engineering and Design of Chimeric Antigen ReceptorsSemantic proximity Read

Fully human CD19-specific chimeric antigen receptors for T-cell therapySemantic proximity Read

The rules of T-cell engagement: current state of CAR T cells and bispecific antibodies in B-cell lymphomasSemantic proximity Read

Chimeric antigen receptor-modified T cells strike backSemantic proximity Read

Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospectsSemantic proximity Read

The therapeutic landscape for cells engineered with chimeric antigen receptorsSemantic proximity Read

The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell TherapiesSemantic proximity Read

Chimeric antigen receptor signaling: Functional consequences and design implicationsSemantic proximity Read